Table 4.

Results by analysis scenario and base-case comparison

Scenario 1	2012		2030 scenario 1		2030 scenario 1 vs 2012		2030 scenario 1 vs 2030 base-case
Prevalence (n)	1,242,682		566,521		−676,161		−15,688
95% CI (min, max)	917,150	1,568,213	402,842	730,200	−514,309	−838,013	−9,336	−22,039
Health care cost (€million)	€527.0		€334.9		−€192.0		−€11.1
95% CI (min, max)	€388	€666	€232	€438	−€156	−€228	−€7.1	−€15.0
Scenario 2	2012		2030 scenario 2		2030 scenario 2 vs 2012		2030 scenario 2 vs 2030 base-case
Prevalence (n)	1,242,682		556,323		−686,358		−25,885
95% CI (min, max)	917,150	1,568,213	389,842	722,805	−527,308	−845,408	−22,336	−29,434
Health care costs (€million)	€527.0		€327.6		−€199.3		−€18.3
95% CI (min, max)	€388	€666	€223	€432	−€165	−€234	−€16.2	−€20.5
Scenario 3	2012		2030 scenario 3		2030 scenario 3 vs 2012		2030 scenario 3 vs 2030 base-case
Prevalence (n)	1,242,682		520,909		−721,772		−61,299
95% CI (min, max)	917,150	1,568,213	348,154	693,665	−568,996	−874,548	−64,024	−58,574
Health care costs (€million)	€527.0		€302.0		−€224.9		−€44.0
95% CI (min, max)	€388	€666	€194	€410	−€194	−€256	−€42.2	−€45.8

Abbreviations: CI, confidence interval; n, number of subjects; min, minimum; max, maximum; vs, versus.